论文部分内容阅读
目的:观察与分析醒脑静注射液在急性重症脑血管病治疗中的运用情况。方法:选取2014年7月至2015年7月该院所接收的82例急性重症脑血管病患者作为观察对象,按就诊单双数顺序法分成研究组与参照组,参照组予以常规药物治疗,在此基础之上,对研究组患者采取醒脑静注射液治疗;观察与比较两组患者的临床治疗效果。结果:研究组患者治疗后的总有效率(95.1%)明显比参照组(73.2%)高,差异具备统计学意义(P<0.05);就治疗后的NIHSS评分而言,研究组患者低于参照组,差异有统计学意义(P<0.05);研究组患者的不良反应发生率(0.0%)比参照组(12.2%)低,差异存在统计学意义(P<0.05)。结论:对急性重症脑血管病患者采取醒脑静注射液进行治疗,效果显著,且可改善其神经功能,降低不良反应的发生,值得在临床上大力推行。
Objective: To observe and analyze the use of Xingnaojing injection in the treatment of acute severe cerebrovascular disease. Methods: From July 2014 to July 2015, 82 patients with acute severe cerebrovascular disease received by the institute were selected as observation subjects and divided into study group and reference group according to single and double order of attendance. The reference group was given routine drug treatment, On this basis, the study group to take Xingnaojing injection treatment; observation and comparison of two groups of patients with clinical treatment. Results: The total effective rate (95.1%) after treatment in study group was significantly higher than that in the reference group (73.2%), the difference was statistically significant (P <0.05); for the NIHSS score after treatment, the study group was lower than (P <0.05). The incidence of adverse reactions in the study group (0.0%) was lower than that in the reference group (12.2%), the difference was statistically significant (P <0.05). Conclusion: The treatment of acute severe cerebrovascular disease patients with Xingnaojing injection, the effect is significant, and can improve their neurological function, reduce the incidence of adverse reactions, it is worth vigorously promote the clinical.